Viltas: Vildagliptin50mg tablet
Viltas -M:Vildagliptin 50mg + Metformin 500mg tablet
Viltas -MSR:Vildagliptin 50mg + Metformin 500mg SR tablet
Viltas -EM:Vildagliptin 50mg + Metformin 850mg tablet
Viltas -DM:Vildagliptin 50mg + Metformin 1000mg tablet
Viltas -DMSR:Vildagliptin 50mg + Metformin 1000mg SR tablet
Viltas OD: Vildagliptin 100mg SR Tablet
Viltas: Vildagliptin50mg tablet
Viltas -M:Vildagliptin 50mg + Metformin 500mg tablet
Viltas -MSR:Vildagliptin 50mg + Metformin 500mg SR tablet
Viltas -EM:Vildagliptin 50mg + Metformin 850mg tablet
Viltas -DM:Vildagliptin 50mg + Metformin 1000mg tablet
Viltas -DMSR:Vildagliptin 50mg + Metformin 1000mg SR tablet
Viltas OD: Vildagliptin 100mg SR Tablet
Viltas: For the treatment of Type 2 Diabetes Mellitus as a monotherapy adjunct to diet and exercise.
Viltas M & DM: For monotherapy resistant Diabetes Mellitus
How it works
Vildagliptin: In response to a meal, active glucagon-like peptide-1 (GLP-1) is secreted by the L cells of the intestines. Without the presence of vildagliptin, GLP-1 is rapidly inactivated and degraded by the enzyme dipeptidyl peptidase IV (DPP4); when vildagliptin is present, vildagliptin binds to DPP4, allowing GLP-1 to remain active. Active GLP-1 causes the pancreas to increase insulin release and decrease glucagon release.
Metformin: Helps decrease hepatic (liver) glucose production, to decrease GI glucose absorption and to increase target cell insulin sensitivity. Also used as an adjunct to DPP-4 inhibitors, diet, exercise and lifestyle changes such as weight loss to improve glycemic (blood sugar) control in adults with type 2 diabetes
Indications
Viltas: For the treatment of Type 2 Diabetes Mellitus as a monotherapy adjunct to diet and exercise.
Viltas M & DM: For monotherapy resistant Diabetes Mellitus
Dosage
OD / BD therapy depending upon blood glucose level
Help decreases HbA1c, fasting plasma glucose levels and prandial glucose levels
Side Effects
Headache, Cough, Constipation, Sweating, Hypoglycaemia, Weakness, Excessive sweating, Heartburn
Contraindication
Any patient with a known hypersensitivity to Vildagliptin, Metformin or any of the components in the formulation,
Severe ketosis, diabetic coma or history of diabetic coma, type 1 diabetic patients,
Patients with severe infection, surgery, severe trauma (blood sugar control should preferably be done by insulin).
Copyright © 2020 tasmed
.png)
